Day 2 at the 2017 annual meeting of the American Society of Clinical Oncology further highlighted immunotherapy's potential to treat many of the most common types of cancer. Here is an overview of the data coming out of today's session:
Multiple Tumor Types:
Stomach & Gastrointestinal Cancer:
Come back for more updates from tomorrow's presentations.
June is Cancer Immunotherapy Month
Read Previous Article
ASCO17: Day 2 Immunotherapy Highlights
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Let’s stream for a cause. Make time spent watching your favorite movies and TV shows meaningful.
This July for Sarcoma Awareness Month, we look at new research, new treatments, and how we’re working toward a future immune to sarcoma.